Show Summary Details

Page of

PRINTED FROM OXFORD HANDBOOKS ONLINE ( © Oxford University Press, 2018. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Handbooks Online for personal use (for details see Privacy Policy and Legal Notice).

date: 30 November 2020

Abstract and Keywords

This chapter examines the issues, advantages, and liabilities associated with the combination of pharmacotherapy and cognitive-behavioral therapy (CBT) for the treatment of anxiety and mood disorders. It begins with a brief review of the relative efficacy of CBT and pharmacotherapy in the treatment of depression and anxiety disorders before turning to a discussion of issues that arise from combination treatment for anxiety disorders as well as bipolar disorder, schizophrenia, and adult attention-deficit/hyperactivity disorder. The chapter then considers preference and tolerability with respect to combined treatment modality, along with the availability of each treatment modality. It also asks whether CBT should be added to pharmacotherapy, and vice versa, for mood or anxiety disorders and concludes by outlining new research directions for such combination strategies.

Keywords: combination treatment, cognitive-behavioral therapy, pharmacotherapy, anxiety, depression, affective disorders, relapse, maintenance

Access to the complete content on Oxford Handbooks Online requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can''t find the answer there, please contact us.